ROIVANT SCIENCES LTD (ROIV) Stock Income Statement
NASDAQ:ROIV - Nasdaq - BMG762791017 - Common Stock - Currency: USD
| 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 29.05M | 32.71M | 61.28M | 55.29M | 23.80M | |||
| Minority Interest Expense | 184.75M | 117.72M | 106.43M | 78.85M | 91.00M | |||
| Cost Of Goods | 911.00K | 1.60M | 13.13M | 8.97M | 2.06M | |||
| Gross Profit | 28.14M | 31.11M | 48.15M | 46.32M | 21.74M | |||
| Operating Expenses | 1.14B | 856.04M | 1.22B | 1.40B | 1.09B | |||
| Research and Development | 550.41M | 439.91M | 622.96M | 622.93M | 832.76M | |||
| Selling, General, and Administrative Expenses | 591.41M | 416.13M | 600.51M | 775.03M | 259.88M | |||
| Operating Income | -1.11B | -824.93M | -1.18B | -1.35B | -1.07B | |||
| Interest Income/Expense | 313.56M | 98.45M | -16.60M | 349.79M | 90.39M | |||
| Other Income/Expense | 5.04M | -60.40M | -62.19M | 6.59M | -33.41M | |||
| Non Recurring Items | 113.50M | 5.35B | 29.28M | 71.51M | 115.36M | |||
| Income Before Taxes | -681.59M | 4.57B | -1.22B | -923.75M | -898.55M | |||
| Income Tax | 48.17M | 21.50M | 5.19M | 370.00K | 1.69M | |||
| Net Income | -171.98M | 4.35B | -1.01B | -845.26M | -809.23M | |||
| EBITDA | -1.10B | -802.89M | -1.16B | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.23 | 5.23 | -1.41 | -1.26 | -1.18 | |||
| Non GAAP EPS | -0.25 | -1.27 | -1.59 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 96.86% | 95.11% | 78.57% | 83.78% | 91.34% | |||
| Profit Margin | -591.96% | 13294.18% | -1646.59% | -1528.78% | -3400.13% | |||
| Operating Profit Margin | -3833.27% | -2521.71% | -1917.95% | -2444.64% | -4499.54% | |||
All data in USD